Background: Although pruritus is a common complaint in patients with diabetes, little is known about its relation with glycemic control.
Objectives: We investigated whether generalized pruritus is associated with glycemic control in patients with type 2 diabetes.
Materials And Methods: A total of 385 patients with type 2 diabetes who attended the diabetes care system underwent cutaneous examination by a dermatologist at a teaching hospital in Taiwan. A detailed interview questionnaire including visual analogue scale was used to assess various characteristics and the intensity of pruritus. Multivariate logistic regression was used to assess the association between postprandial blood glucose, preprandial blood glucose, and glycosylated hemoglobin with generalized pruritus.
Results: Generalized pruritus was noted in 27.5% of the patients. As a result of pruritus, 24.5% of the patients had difficulties in falling asleep, 15.1% had disturbance of sleep, and 9.5% needed soporifics. Patients who had a higher postprandial glucose level had a higher probability of having generalized pruritus [OR = 1.41 (95% C.I.: 1.05-1.90), P = 0.02] in type 2 diabetic patients.
Conclusions: This study showed positive associations between postprandial blood glucose and generalized pruritus and suggested that a better control of postprandial glucose might be beneficial to relieve generalized pruritus in diabetic patients.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1684/ejd.2013.2100 | DOI Listing |
Vet Parasitol Reg Stud Reports
January 2025
Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran. Electronic address:
Pediculosis caused by chewing lice may pose a threat to domesticated and wild birds' health. These ectoparasites can cause pruritus, poor feather condition and do weaken hosts making them susceptible to other infections. Species of the genus Saemundssonia which are called ecomorphic head lice parasitize a wide range of aquatic birds from the family Laridae.
View Article and Find Full Text PDFDermatol Ther (Heidelb)
January 2025
Department of Clinical and Molecular Sciences-Dermatological Clinic, Università Politecnica Delle Marche, Ancona, Italy.
Introduction: Palmoplantar psoriasis (PPp) has a profound negative impact on patients' quality of life, and it represents a therapeutic challenge, as palms and soles are difficult to treat area. Although the efficacy profile of tildrakizumab has been well evaluated in the literature, data on its use for PPp are still limited. The objective of the study was to evaluate the efficacy and safety of tildrakizumab on moderate-to-severe plaque psoriasis with involvement of the palmoplantar area.
View Article and Find Full Text PDFAllergy
January 2025
Department of Dermatology, Tianjin Institute of Integrative Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
Background: The efficacy and safety of dupilumab in patients with refractory prurigo nodularis (PN) is well established in clinical trials, but there is a lack of multicenter data regarding its effectiveness and safety in real-world settings.
Methods: Patients with moderate-to-severe PN who initiated dupilumab treatment between July 2023 and January 2024, with a follow-up period of at least 16 weeks at 10 hospitals in China were included. We used peak pruritus numeric rating scale (PP-NRS), investigator global assessment (IGA) for PN, and dermatology life quality index for adults or children (DLQI/CDLQI) to assess disease control status and quality of life impairment, and monitored adverse events to assess the safety.
Int J Surg Case Rep
January 2025
Department of Vascular Surgery, The third hospital of mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, China.
Introduction And Importance: A traumatic arteriovenous fistula (TAVF) is a vascular injury where an artery and a vein become abnormally connected. Although endovascular intervention is often the first choice for TAVF, some special cases still require open surgery.
Case Presentation: A 65-year-old man developed a chronic AVF in the lower superficial femoral artery (SFA) one year after a farming accident.
Liver Int
February 2025
Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada.
Background: Alagille syndrome (ALGS) is a multisystem cholestatic disorder. Maralixibat is approved for the treatment of cholestatic pruritus in ALGS with limited data in adults.
Methods: Participants were included if they received ≥ 2 doses of maralixibat at age ≥ 16 years in one of the three previously published maralixibat ALGS clinical trials.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!